Assay of ischemia-modified albumin and C-reactive protein for early diagnosis of acute coronary syndromes

Journal of Clinical Laboratory Analysis

Volumn 22, Issue 1, 2008, Pages 45-49

  Liyan, Cui ^a   Jie, Zhang ^a   Yonghua, Wu ^a   Xiaozhou, Hu ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

C reactive protein (CRP); Myocardial ischemia; ROC curve

Indexed keywords

C REACTIVE PROTEIN; COBALT; ISCHEMIA MODIFIED ALBUMIN;

ACUTE CORONARY SYNDROME; ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BINDING; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THORAX PAIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL ASSAY; C-REACTIVE PROTEIN; FEMALE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; ROC CURVE; SERUM ALBUMIN;

EID: 39449133939     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20223     Document Type: Article

References (19)

1. Chrysohoou C, Pitsavos C, Panagiotakos DB, Kokkinos PF, Stefanadis C, Toutouzas P. The association between physical activity and the development of acute coronary syndromes in treated and untreated hypertensive subjects. J Clin Hypertens (Greenwich) 2003;5:115-120.
2. Collinson PO, Premachandram S, Hashemi K. Prospective audit of incidence of prognostically important myocardial damage in patients discharged from emergency department. BMJ 2000;320:1702-1705.
3. Ross R. Atherosclerosis - an inflammatory disease. New Engl J Med 1999;340:115-126.
4. Nikfardjam M, Mullner M, Schreiber W, et al. The association between C-reactive protein on admission and mortality in patients with acute myocardial infarction. J Intern Med 2000;247:341-345.
5. Sulerman M, Aronson D, Reisner SA, et al. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med 2003;115:695-701.
6. Zairis MN, Manousakis SJ, Stefanidis AS, et al. C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarction. Am Heart J 2002;144:782-789.
7. Foussas SG, Zairis MN, Lyras AG, et al. Early prognostic usefulness of C-reactive protein added to the thrombolysis in myocardial infarction risk score in acute coronary syndromes. Am J Cardiol 2005;96:533-537.
8. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin During Instability in Coronary Artery Disease. N Engl J Med 2000;343:1139-1147.
9. Mueller C, Buettner HJ, Hodgson JM, et al. Inflammation and long-term mortality after non-ST-elevation acute syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 2002;105:1412-1415.
10. Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin During Instability in Coronary Artery Disease. Circulation 1997;96:4204-4210.
11. Zebrack JS, Anderson JL, Beddhu S, et al. Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency? J Am Coll Cardiol 2003;42:57-63.
12. Christenson RL, Duh SH, Sanhai WR, et al. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464-470.
13. Wu AB, Morris DL, Fletcher DR, et al. Analysis of the albumin cobalt binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction. Cardiovasc Toxicol 2001;1:147-151.
14. Bhagavan NV, Lai EM, Rios RA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003;49:581-585.
15. Anwaruddin S, Januzzi JL Jr, Baggish AL, et al. Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol 2005;123:140-145.
16. Sinha MK, Roy D, Gaze DC, et al. Role of "ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29-34.
17. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424.
18. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-163.
19. Berenshtein E, Mayer B, Goldberg C, Kitrossky N, Chevion M. Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injury. J Mol Cell Cardiol 1997;29:3025-3034.